Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
Breast Cancer
DRUG: exemestane
bioequivalence determined by statistical comparison Cmax, 21 days
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions